Lessons in human biology from a monogenic pancreatic β cell disease

Journal of Clinical Investigation

Volumn 121, Issue 10, 2011, Pages 3821-3824

  Glaser, Benjamin ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; PINACIDIL;

ALLELE; GENE EXPRESSION; GENE MUTATION; HUMAN; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PATHOPHYSIOLOGY; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; TREATMENT RESPONSE;

DIAZOXIDE; HUMANS; INSULIN; ISLETS OF LANGERHANS; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY;

EID: 80053391603     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60002     Document Type: Note

References (22)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053. (Pubitemid 38579764)
2. Henquin J-C, et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest. 2011;121(10):3932-3942.
3. Glaser B, Landau H, Permutt MA. Neonatal hyperinsulinism. Trends Endocrinol Metab. 1999;10(2):55-61. (Pubitemid 29287823)
4. Thomas PM, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268(5209):426-429.
5. Rahier J. Relevance of endocrine pancreas nesidioblastosis to hyperinsulinemic hypoglycemia. Diabetes Care. 1989;12(2):164-166. (Pubitemid 19064414)
6. Heitz PU, Kloppel G, Hacki WH, Polak JM, Pearse AG. Nesidioblastosis: the pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy. Diabetes. 1977;26(7):632-642. (Pubitemid 8149650)
7. Fournet JC, et al. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia. Ann Endocrinol (Paris). 1998;59(6):485-491.
8. Ryan FD, et al. Hyperinsulinism: The molecular aetiology of focal disease. Arch Dis Child. 1998;79(5):445-447.
9. Straub SG, et al. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways. Diabetes. 2001;50(2):329-339. (Pubitemid 32127290)
10. Kane C, et al. Loss of functional KATP channels in pancreatic β-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med. 1996;2(12):1344-1347. (Pubitemid 26401737)
11. Aynsley-Green A. Nesidioblastosis of the pancreas in infancy. Dev Med Child Neurol. 1981;23(3):372-379. (Pubitemid 11125519)
12. Kaiser N, et al. Regulation of insulin release in persistent hyperinsulinaemic hypoglycaemia of infancy studied in long-term culture of pancreatic tissue. Diabetologia. 1990;33(8):482-488. (Pubitemid 20254871)
13. Otonkoski T, Andersson S, Simell O. Somatostatin regulation of β-cell function in the normal human fetuses and in neonates with persistent hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab. 1993;76(1):184-188. (Pubitemid 23027577)
14. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. β-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49(8):1325-1333. (Pubitemid 30624233)
15. De Lonlay P, et al. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr. 2002;161(1):37-48. (Pubitemid 34031274)
16. Grimberg A, et al. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes. 2001;50(2):322-328. (Pubitemid 32127289)
17. Uhde I, Toman A, Gross I, Schwanstecher C, Schwanstecher M. Identification of the potassium channel opener site on sulfonylurea receptors. J Biol Chem. 1999;274(40):28079-28082.
18. Glaser B, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998;338(4):226-230. (Pubitemid 28047576)
19. Stanley CA, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338(19):1352-1357. (Pubitemid 28216664)
20. Otonkoski T, et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic β cells. Am J Hum Genet. 2007;81(3):467-474. (Pubitemid 47330206)
21. Hardy OT, et al. Functional genomics of the β-cell: short-chain 3-hydroxyacyl-coenzyme A dehydrogenase regulates insulin secretion independent of K+ currents. Mol Endocrinol. 2007;21(3):765-773.
22. Li C, et al. Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem. 2010;285(41):31806-31818.